menu close
adarx.com

ADARx Pharmaceuticals Stock

Company Profile:

ADARx Pharmaceuticals is focused on developing innovative RNA-targeting therapies that aim to treat a broad range of serious diseases. The company is working on creating oligonucleotide-based therapeutics for gene editing, inhibition, and degradation, with an emphasis on addressing unmet medical needs in genetic, cardiometabolic, and central nervous system diseases.

Sign up for SecondMarket™ to view the market and buy or sell ADARx Pharmaceuticals Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

ADARx Pharmaceuticals Management Team

  • Director

    Ricky Sun

  • Director

    Chen Yu

  • Director

    Simeon J. George

  • Chief Medical Officer

    Chris Stogard

  • Director

    Judith Li

  • Director

    Sheila Gujrathi

  • President, CEO

    Zhen Li

  • Director

    Lorence Kim

  • CFO

    Ajim Tamboli

  • Director

    Yuan Sun

  • Director

    Carl L. Gordon

  • Director

    Erez Chimovits

Learn More About ADARx Pharmaceuticals Stock

Buy ADARx Pharmaceuticals Stock
01

ADARx Pharmaceuticals stock does not trade on public stock exchanges. ADARx Pharmaceuticals stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ADARx Pharmaceuticals stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell ADARx Pharmaceuticals Stock
02

ADARx Pharmaceuticals Stock does not trade on public stock exchanges. In order to sell ADARx Pharmaceuticals shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

ADARx Pharmaceuticals Stock Price
03

ADARx Pharmaceuticals does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view ADARx Pharmaceuticals share price and other valuable private market data.

Read more about secondary market private company stock prices:

ADARx Pharmaceuticals Stock Ticker Symbol
04

There is no ticker symbol for ADARx Pharmaceuticals stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell ADARx Pharmaceuticals Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ADARx Pharmaceuticals stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in ADARx Pharmaceuticals Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ADARx Pharmaceuticals stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

ADARx Pharmaceuticals Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

ADARx Pharmaceuticals IPO
08

ADARx Pharmaceuticals is a private company and has not had an IPO. There is currently no ADARx Pharmaceuticals IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to ADARx Pharmaceuticals IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell ADARx Pharmaceuticals Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Solugen-Logo

Solugen

Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.

Source: Nasdaq Private Market Tape D™